Keros Therapeutics (KROS) Income Statement (2019 - 2026)
Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Keros Therapeutics (KROS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||||||
Total Revenue | 370K (-5.13%) | 390K (-97.27%) | 14M (-21.52%) | 18M (-91.40%) | 211M (+6849.01%) | 3.04M (+679.49%) | 390K (+875.00%) | 40K (-50.00%) | 80K (-42.86%) | 140K (+1300.00%) | 10K | - | - | - | - | - | - | 20M | - | 100K | - | - | - | - | - | 2.50M (0.00%) | 2.50M (0.00%) | 2.50M (0.00%) | 2.50M |
Operating Expenses | |||||||||||||||||||||||||||||
Research And Development | 16M (-10.11%) | 18M (-8.25%) | 20M (-55.13%) | 44M (-10.70%) | 49M (+6.75%) | 46M (-7.31%) | 49M (+21.50%) | 41M (+5.91%) | 38M (+2.05%) | 37M (+9.81%) | 34M (+4.95%) | 33M (+4.63%) | 31M (+25.01%) | 25M (+18.20%) | 21M (-9.62%) | 23M (+28.76%) | 18M (-3.98%) | 19M (+26.97%) | 15M (+48.60%) | 9.98M (-13.22%) | 12M (+18.92%) | 9.67M (+15.12%) | 8.40M (+15.70%) | 7.26M (-14.89%) | 8.53M (+105.05%) | 4.16M (+8.05%) | 3.85M (-14.44%) | 4.50M (-7.60%) | 4.87M |
Selling General And Administrative | 10M (-13.54%) | 12M (+15.89%) | 10M (-30.04%) | 14M (+37.90%) | 11M (-1.59%) | 11M (+8.66%) | 9.82M (-1.41%) | 9.96M (-3.39%) | 10M (+13.17%) | 9.11M (-0.44%) | 9.15M (+3.98%) | 8.80M (+13.11%) | 7.78M (+9.73%) | 7.09M (+2.16%) | 6.94M (-6.85%) | 7.45M (+23.14%) | 6.05M (+0.33%) | 6.03M (+12.29%) | 5.37M (-5.12%) | 5.66M (+32.55%) | 4.27M (+17.96%) | 3.62M (+1.97%) | 3.55M (-2.74%) | 3.65M (+84.34%) | 1.98M (+85.05%) | 1.07M (+10.31%) | 970K (+49.23%) | 650K (+32.65%) | 490K |
Operating Expenses | 26M (-11.53%) | 30M (+0.03%) | 30M (-48.87%) | 58M (-2.06%) | 59M (+5.17%) | 56M (-4.66%) | 59M (+16.98%) | 50M (+3.93%) | 49M (+4.23%) | 47M (+7.65%) | 43M (+4.72%) | 41M (+6.35%) | 39M (+21.62%) | 32M (+14.22%) | 28M (-8.95%) | 31M (+27.35%) | 24M (-2.98%) | 25M (+23.12%) | 20M (+29.16%) | 16M (-0.82%) | 16M (+18.66%) | 13M (+11.21%) | 12M (+9.53%) | 11M (+3.90%) | 11M (+100.76%) | 5.23M (+8.28%) | 4.83M (-6.21%) | 5.15M (-3.92%) | 5.36M |
Depreciation And Amortization | 400K (-65.81%) | 1.17M | - | - | 340K (-64.21%) | 950K | - | - | 280K (-56.92%) | 650K | - | - | 170K (-69.64%) | 560K | - | - | 110K (-63.33%) | 300K | - | - | 80K (-63.64%) | 220K | - | - | 60K (-62.50%) | 160K | - | - | 50K |
Operating Income | |||||||||||||||||||||||||||||
Operating Income | -25.88M (-11.58%) | -29.27M (+90.31%) | -15.38M (-61.38%) | -39.82M | 152M | -53.25M (-9.22%) | -58.66M (+16.30%) | -50.44M (+4.04%) | -48.48M (+4.37%) | -46.45M (+7.32%) | -43.28M (+4.69%) | -41.34M (+6.35%) | -38.87M (+21.62%) | -31.96M (+14.22%) | -27.98M (-8.95%) | -30.73M (+27.35%) | -24.13M (+395.48%) | -4.87M (-75.89%) | -20.20M (+29.99%) | -15.54M (-1.46%) | -15.77M (+18.66%) | -13.29M (+11.21%) | -11.95M (+9.53%) | -10.91M (+3.90%) | -10.50M (+284.62%) | -2.73M (+17.17%) | -2.33M (-12.08%) | -2.65M (-7.34%) | -2.86M |
Ebit | -25.88M (-11.58%) | -29.27M (+90.31%) | -15.38M (-61.38%) | -39.82M | 152M | -53.25M (-9.22%) | -58.66M (+16.30%) | -50.44M (+4.04%) | -48.48M (+4.37%) | -46.45M (+7.32%) | -43.28M (+4.69%) | -41.34M (+6.35%) | -38.87M (+21.62%) | -31.96M (+14.22%) | -27.98M (-8.95%) | -30.73M (+27.35%) | -24.13M (+395.48%) | -4.87M (-75.89%) | -20.20M (+29.99%) | -15.54M (-1.46%) | -15.77M (+18.66%) | -13.29M (+11.21%) | -11.95M (+9.53%) | -10.91M (+3.90%) | -10.50M (+284.62%) | -2.73M (+17.17%) | -2.33M (-12.08%) | -2.65M (-7.34%) | -2.86M |
EBITDA | -25.47M (-38.89%) | -41.68M (+379.08%) | -8.70M (-73.57%) | -32.92M | 152M | -63.18M (+19.30%) | -52.96M (+17.01%) | -45.26M (-6.12%) | -48.21M (-9.85%) | -53.48M (+35.60%) | -39.44M (+5.15%) | -37.51M (-3.07%) | -38.70M (-1.60%) | -39.33M (+67.29%) | -23.51M (-13.79%) | -27.27M (+13.58%) | -24.01M (+451.95%) | -4.35M (-78.60%) | -20.33M (+30.15%) | -15.62M (-0.45%) | -15.69M (+19.32%) | -13.15M (+9.31%) | -12.03M (+11.80%) | -10.76M (+3.07%) | -10.44M (+815.79%) | -1.14M (-67.89%) | -3.55M (+24.56%) | -2.85M (+1.42%) | -2.81M |
Other Income / Expenses | |||||||||||||||||||||||||||||
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -10.00K | - | - | - |
Other Non Operating Income | -170.00K (-68.52%) | -540.00K (+116.00%) | -250.00K (+13.64%) | -220.00K (-35.29%) | -340.00K (-64.21%) | -950.00K (+955.56%) | -90.00K (-55.00%) | -200.00K (-54.55%) | -440.00K (+109.52%) | -210.00K (+200.00%) | -70.00K (-53.33%) | -150.00K (+275.00%) | -40.00K (-93.44%) | -610.00K | 760K (+744.44%) | 90K | -60.00K (-84.21%) | -380.00K (+171.43%) | -140.00K (+75.00%) | -80.00K (+33.33%) | -60.00K | 160K | -90.00K | 160K | -70.00K | 240K (+1100.00%) | 20K (-71.43%) | 70K (-30.00%) | 100K |
Net Income | |||||||||||||||||||||||||||||
Income Before Tax | -23.71M (-5.05%) | -24.97M (+187.01%) | -8.70M (-73.57%) | -32.92M | 158M | -45.73M (-13.65%) | -52.96M (+17.01%) | -45.26M (+4.99%) | -43.11M (-71.82%) | -152.99M | - | - | - | -29.72M (+26.41%) | -23.51M (-13.79%) | -27.27M (+12.73%) | -24.19M (+389.68%) | -4.94M (-75.70%) | -20.33M (+30.15%) | -15.62M (-1.33%) | -15.83M (+48.22%) | -10.68M (-11.30%) | -12.04M (+11.90%) | -10.76M (-10.78%) | -12.06M (+338.55%) | -2.75M (-22.54%) | -3.55M (+24.56%) | -2.85M (-10.38%) | -3.18M |
Income Tax Expense | - | -1.51M (+6.34%) | -1.42M (-36.04%) | -2.22M | 10M (+3246.67%) | 300K | - | - | - | - | - | - | - | - | - | - | - | 2.00M | -40.00K | - | 50K | - | - | - | -170.00K | - | - | - | - |
Net Income From Continuing Operations | -23.71M (+1.07%) | -23.46M (+222.25%) | -7.28M (-76.29%) | -30.70M | 148M | -46.03M (-13.09%) | -52.96M (+17.01%) | -45.26M (+4.99%) | -43.11M (+7.13%) | -40.24M (+2.03%) | -39.44M (+5.15%) | -37.51M (+4.78%) | -35.80M (+20.46%) | -29.72M (+26.41%) | -23.51M (-13.79%) | -27.27M (+12.73%) | -24.19M (+248.56%) | -6.94M (-65.81%) | -20.30M (+29.96%) | -15.62M (-1.64%) | -15.88M (+48.69%) | -10.68M (-11.30%) | -12.04M (+11.90%) | -10.76M (-9.50%) | -11.89M (+332.36%) | -2.75M (-22.54%) | -3.55M (+24.56%) | -2.85M (-10.38%) | -3.18M |
Net Income | -23.71M (+1.07%) | -23.46M (+222.25%) | -7.28M (-76.29%) | -30.70M | 148M | -46.03M (-13.09%) | -52.96M (+17.01%) | -45.26M (+4.99%) | -43.11M (+7.13%) | -40.24M (+2.03%) | -39.44M (+5.15%) | -37.51M (+4.78%) | -35.80M (+20.46%) | -29.72M (+26.41%) | -23.51M (-13.79%) | -27.27M (+12.73%) | -24.19M (+248.56%) | -6.94M (-65.81%) | -20.30M (+29.96%) | -15.62M (-1.64%) | -15.88M (+48.69%) | -10.68M (-11.30%) | -12.04M (+11.90%) | -10.76M (-9.50%) | -11.89M (+332.36%) | -2.75M (-22.54%) | -3.55M (+24.56%) | -2.85M (-10.38%) | -3.18M |